Follow The Filings

FRPH FRP

FRP earnings company data as of 8:02 PM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by FRPH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FRPH insider trades
  • $10.7M bought by 3 insiders
  • $82K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. John D Baker II Director
    Buy
    $201K 9,146 shares at $21.97 +0.3% to stake
    Traded Aug 17–18 Filed Aug 18
  2. John D. Baker III CEO
    Buy
    $149K 6,800 shares at $21.91 +2.3% to stake
    Traded Aug 7 Filed Aug 11
  3. John D Baker II Director
    Buy
    $10M 478,468 shares at $20.90 +19% to stake
    Traded Mar 23 Filed Mar 25
  4. John D Baker II Director
    Buy
    $181K 6,608 shares at $27.45 +3.6% to stake
    Traded Mar 14, 2025 Filed Feb 19
  5. David H deVilliers III COO
    Sale
    $35K 1,500 shares at $23.42 2.6% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
  6. David H Devilliers Jr. COO
    Sale
    $46K 2,000 shares at $23.23 2.5% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
  7. John D Baker II Director
    Buy
    $20K 854 shares at $23.85 +0.4% to stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
  8. Matthew C. McNulty CFO
    Buy
    $48K 2,000 shares at $23.89 +8.7% to stake
    Traded Nov 12–13 Filed Nov 13, 2025
  9. John D Baker II Director
    Buy
    $171K 7,175 shares at $23.85 +3.7% to stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
  10. John D. Baker III CEO
    Buy
    $99K 4,166 shares at $23.70 +1.9% to stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  11. John D Baker II Director
    Buy
    $7,849 334 shares at $23.50 +0.2% to stake
    Traded Nov 10, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 8 gifts, 4 sales back to the company, 2 option exercises, and 2 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 4.01,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
DEF 14A
10-K
8-K 2.02,9.01
SCHEDULE 13D/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.